[Rheumatoid arthritis in elderly people]
Clicks: 422
ID: 113523
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
75.7
/100
422 views
290 readers
Trending
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #4 of 18 articles by views in Wiadomosci lekarskie (Warsaw, Poland : 1960)
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Rheumatoid arthritis (RA) is a chronic, systemic connective tissue disease, characterized by progressive, destructive polyarthritis with internal organs involvement due to active, systemic inflammation. The onset of disease occurs usually in 4th or 5th decade of life. Since the general population is …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (42 words).
Try re-searching for a better abstract.
| Reference Key |
b2019wiadomosci[rheumatoid
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Targońska-Stępniak B;; |
| Journal | Wiadomosci lekarskie (Warsaw, Poland : 1960) |
| Year | 2019 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
inflammation
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
female
male
aged
Bozena Targońska-Stepniak
arthritis
glucocorticoids / therapeutic use
pmid:31586982
age of onset
rheumatoid / diagnosis*
rheumatoid / therapy
methotrexate / therapeutic use
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.